GLP-1 Drugs Like Ozempic and Fertility: What's Actually Known
Early research links GLP-1 drugs like semaglutide (Ozempic/Wegovy) to more regular ovulation in women with PMOS/PCOS and better sperm quality in men with obesity -- largely through weight loss and improved insulin sensitivity. But these drugs aren't approved as fertility treatments, aren't safe during pregnancy, and need an 8-10 week washout before you start trying.
If you've spent any time on fertility TikTok or Reddit lately, you've probably run into someone's "Ozempic baby" story: years of irregular cycles, a GLP-1 prescription for weight loss or diabetes, and then a surprise positive test. It's a great anecdote. It's also not the same thing as evidence -- so let's look at what the actual research says about GLP-1 drugs and fertility, for both women and men.
What GLP-1 drugs are, quickly
Semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) belong to a drug class called GLP-1 receptor agonists. They mimic a gut hormone that regulates blood sugar and appetite, which is why they were originally developed for type 2 diabetes and are now widely used for weight loss. Neither was designed with fertility in mind -- any reproductive effects are, so far, a side effect of what they were built to do.
The PMOS/PCOS connection
This is where the strongest signal is. A 2026 narrative review that pooled 47 studies on GLP-1 drugs and reproductive outcomes found consistent metabolic benefits and emerging evidence of improved ovulation and pregnancy rates in women with PMOS (formerly PCOS), especially when a GLP-1 drug was combined with metformin. In one randomized trial cited in that review, women taking liraglutide plus metformin had a pregnancy rate of 69.2%, compared to 35.4% on metformin alone. Another trial found ovulation rates as high as 86% with exenatide plus metformin.
The mechanism isn't mysterious: PMOS is closely tied to insulin resistance, and insulin resistance interferes with ovulation. GLP-1 drugs improve insulin sensitivity and typically produce meaningful weight loss, both of which can help cycles normalize. There's also newer, more speculative research (currently in an ongoing trial called RESTORE, run out of the University of Colorado) looking at whether semaglutide has more direct effects on ovarian tissue itself, separate from weight loss -- that part of the story isn't settled yet.
Worth flagging honestly: rapid, significant weight loss can also disrupt cycles in the short term, the same way it does in athletes or with any fast caloric deficit, since a big chunk of the body's estrogen is stored in fat tissue. So it's not universally "GLP-1s fix your cycle" -- some people see temporary irregularity before things improve.
What about male fertility?
The evidence here is thinner but points in a promising direction. A 2026 review of clinical trial data found GLP-1 drugs may support male reproductive health specifically in men with obesity, with improvements in testosterone levels, other reproductive hormones, and sperm quality alongside the expected metabolic benefits. As with the female research, the leading theory is that this is largely downstream of weight loss and improved metabolic health, rather than some direct effect on the testes -- but it's an active area of study, not settled science.
The part that matters if you're actually trying to conceive
GLP-1 drugs are not approved as fertility treatments, full stop -- any reproductive benefit right now is an observed side effect, not a labeled use. More importantly: they are not considered safe during pregnancy. Animal studies have shown fetal risks, and there's not enough human safety data to say otherwise. If you're on semaglutide or tirzepatide and planning to conceive, the standard advice is an 8-10 week washout period off the medication before you start actively trying, to let it clear your system. Tirzepatide can also reduce how well oral contraceptives work (it slows gastric emptying, which affects absorption), so if you're on the pill specifically to avoid pregnancy rather than trying, that's worth discussing with your prescriber too.
If you do have PMOS/PCOS and irregular cycles, and you're wondering whether a GLP-1 drug might be part of your path to pregnancy, that's a conversation for your doctor or a reproductive endocrinologist -- not a decision to make off a TikTok. And if you're already using ovulation tracking to figure out where you stand, pairing a basic OPK with a PdG confirmation test is a cheap way to see whether cycles are actually normalizing as you go.
References
- Narrative review. (2026). GLP-1 receptor agonists and fertility: What is known so far. PMC (47 studies, 2014-2025).
- Medical News Today. (2026, June 18). How GLP-1 drug semaglutide may play a role in reproductive health.
- University of Colorado Anschutz Medical Campus. (2026, June 12). Injectable semaglutide shows early promise to improve fertility in women with PMOS (RESTORE trial).
Common questions
Can Ozempic actually help me get pregnant?
Indirectly, maybe. If irregular ovulation from PMOS/PCOS or obesity-related hormonal imbalance is part of why you're not conceiving, weight loss and improved insulin sensitivity from a GLP-1 drug can help restore more regular cycles. It's not an approved fertility treatment, though, and results vary a lot by person.
What are 'Ozempic babies'?
A nickname for the anecdotal reports of unexpected pregnancies in people using GLP-1 drugs, especially those with PMOS/PCOS or irregular cycles who assumed they couldn't conceive easily. There's no solid data on how common this actually is -- it's mostly individual stories, not a studied phenomenon.
Is it safe to take a GLP-1 drug while pregnant or trying to conceive?
No. GLP-1 drugs aren't recommended during pregnancy due to limited safety data and fetal risks seen in animal studies. Semaglutide and tirzepatide specifically require an 8-10 week washout period before you start actively trying to conceive.